Observational study / 2014
Optimal PPI use and better GERD symptom control were more frequent among patients prescribed PPIs by gastroenterologists than OTC consumers.
Researchers surveyed 1,959 clinic patients to assess PPI dosing patterns and symptom control in OTC consumers compared to prescription users. Among 610 PPI users with GERD, 71% of patients prescribed PPIs by gastroenterologists were optimal users, compared with 47% prescribed by primary care physicians and 39% of OTC consumers (P<0.001 vs gastroenterologists). GSAS symptom, frequency, and severity scores were significantly better in patients prescribed PPIs by gastroenterologists (P<0.001) and in patients using PPIs optimally compared with suboptimal or excessive users (P<0.001).
Shows an association, not proof of cause and effect.
- Study type
- Cross-sectional survey study
- Who was studied
- 1,959 patients surveyed across five clinics, including 610 PPI users with GERD
- What was measured
- PPI dosing patterns (optimal vs suboptimal) and GERD symptoms via GSAS scores
THE PAPER
Consumer use of over-the-counter proton pump inhibitors in patients with gastroesophageal reflux disease.
Sheikh I, Waghray A, Waghray N, Dong C, Wolfe MM. Am J Gastroenterol, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.